Correlation Engine 2.0
Clear Search sequence regions

  • help (1)
  • humans (1)
  • liver transplant (4)
  • tacrolimus (13)
  • Sizes of these terms reflect their relevance to your search.

    LCP-tacrolimus displays enhanced oral bioavailability compared to immediate-release (IR-) tacrolimus. The ENVARSWITCH study aimed to compare tacrolimus AUC0-24 h in stable kidney (KTR) and liver transplant recipients (LTR) on IR-tacrolimus converted to LCP-tacrolimus, in order to re-evaluate the 1:0.7 dose ratio recommended in the context of a switch and the efficiency of the subsequent dose adjustment. Tacrolimus AUC0-24 h was obtained by Bayesian estimation based on three concentrations measured in dried blood spots before (V2), after the switch (V3), and after LCP-tacrolimus dose adjustment intended to reach the pre-switch AUC0-24 h (V4). AUC0-24 h estimates and distributions were compared using the bioequivalence rule for narrow therapeutic range drugs (Westlake 90% CI within 0.90-1.11). Fifty-three KTR and 48 LTR completed the study with no major deviation. AUC0-24 h bioequivalence was met in the entire population and in KTR between V2 and V4 and between V2 and V3. In LTR, the Westlake 90% CI was close to the acceptance limits between V2 and V4 (90% CI = [0.96-1.14]) and between V2 and V3 (90% CI = [0.96-1.15]). The 1:0.7 dose ratio is convenient for KTR but may be adjusted individually for LTR. The combination of DBS and Bayesian estimation for tacrolimus dose adjustment may help with reaching appropriate exposure to tacrolimus rapidly after a switch. Copyright © 2023 Monchaud, Woillard, Crépin, Tafzi, Micallef, Rerolle, Dharancy, Conti, Choukroun, Thierry, Buchler, Salamé, Garrouste, Duvoux, Colosio, Merville, Anglicheau, Etienne, Saliba, Mariat, Debette-Gratien and Marquet.


    Caroline Monchaud, Jean-Baptiste Woillard, Sabrina Crépin, Naïma Tafzi, Ludovic Micallef, Jean-Philippe Rerolle, Sébastien Dharancy, Filomena Conti, Gabriel Choukroun, Antoine Thierry, Matthias Buchler, Ephrem Salamé, Cyril Garrouste, Christophe Duvoux, Charlotte Colosio, Pierre Merville, Dany Anglicheau, Isabelle Etienne, Faouzi Saliba, Christophe Mariat, Marilyne Debette-Gratien, Pierre Marquet. Tacrolimus Exposure Before and After a Switch From Twice-Daily Immediate-Release to Once-Daily Prolonged Release Tacrolimus: The ENVARSWITCH Study. Transplant international : official journal of the European Society for Organ Transplantation. 2023;36:11366

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 37588007

    View Full Text